Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet
Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet
Authorised
- POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
- Amoxicillin trihydrate
Product identification
Medicine name:
Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet
Active substance:
- POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
- Amoxicillin trihydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)125.10/milligram(s)1.00Tablet
-
Amoxicillin trihydrate229.55/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 250
- Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 100
- Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 10
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
- V.M.D.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V343156
Date of authorisation status change:
Reference member state:
-
Belgium
Procedure number:
- BE/V/0024/002
Concerned member states:
-
Denmark
-
France
-
Germany
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Spain
-
Sweden
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
